Profile picture of PBS
5 takeaways from the abortion pill case before the U.S. Supreme Court: U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans’ access to ...
pbs.org/newshour/politics/5-takeaways-from-the-abortion-pill-case-before-the-u-s-supreme-court
5 takeaways from the abortion pill case before the U.S. Supreme Court
Quick Glance: The Significance of the Supreme Court Mifepristone Case
  • On June 24, 2022, the constitutional jurisprudence on abortions was overturned by the Supreme Court.

  • A pivotal aspect in the dispute FDA v. Alliance for Hippocratic Medicine revolves around making access to medication abortions more challenging.

  • The decision could impact not only abortion access but also have implications for miscarriage treatment.

  • There are also repercussions for the entire country, voters' preferences in blue states, and state sovereignty.
Profile picture of Ars Technica
Tick-killing pill shows promising results in human trial: Should it pan out, the pill would be a new weapon against Lyme disease.
wired.com/story/pill-kills-ticks-lyme-disease-babesiosis-anaplasmosis/
Tick-killing pill shows promising results in human trial
Quick Glance: New Tick-Killing Pill: Hope Against Lyme Disease
  • Tarsus Pharmaceuticals is developing a pill for humans that paralyzes and kills ticks to protect against Lyme disease.

  • The pill has shown promising results in a small trial, killing ticks within 24 hours of drug intake and lasting effects for up to 30 days.

  • The development of this pill could not only protect against Lyme disease but also other tick-borne diseases like babesiosis and anaplasmosis.

  • While the efficacy of the pill in preventing Lyme disease is yet to be proven, cautious optimism surrounds its potential as a preventive measure for individuals in tick-infested areas.
Profile picture of CNN.com
FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice
cnn.com/2024/03/27/health/fda-ivermectin-lawsuit/
FDA settles lawsuit over ivermectin content that doctors claimed harmed ...
Profile picture of Reuters
US FDA approves first drug for fatty liver disease NASH: The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-drug-fatty-liver-disease-nash-2024-03-14/
US FDA approves first drug for fatty liver disease NASH
Quick Glance: First Drug Approval for Fatty Liver Disease NASH by US FDA
  • The US FDA has approved Madrigal Pharmaceuticals' drug for the fatty liver disease NASH.

  • NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH), affects about 1.5 million Americans.

  • The drug will be available in April and is seen as a pivotal moment for patients.

  • Other companies are also conducting trials of their drugs for NASH to meet the much-needed treatment.
Profile picture of NPR
Wegovy is now covered by Medicare, but not for weight loss | Here & Now: Wegovy will be covered to prevent heart problems in people with obesity and heart ...
wbur.org/hereandnow/2024/03/26/wegovy-medicare-weight-loss
Wegovy is now covered by Medicare, but not for weight loss | Here & Now
Profile picture of Los Angeles Times
Hiltzik: The FDA and a bogus COVID treatment : Three right-wing doctors said the FDA's advice against taking ivermectin for COVID infringed on their rights ...
latimes.com/business/story/2024-03-26/column-the-fda-shoots-itself-in-the-foot-by-settling-a-dumb-lawsuit-over-ivermectin
Hiltzik: The FDA and a bogus COVID treatment
Profile picture of Axios (website)
FDA authorizes drug to boost COVID protection for immunocompromised patients: It will offer added protection to high-risk patients who may have weaker responses ...
axios.com/2024/03/25/covid-antibody-fda
FDA authorizes drug to boost COVID protection for immunocompromised ...
Profile picture of ABC
Elon Musk says ketamine can get you out of a 'negative frame of mind'. What does the research say?
abc.net.au/news/2024-03-23/elon-musk-ketamine-negative-state-of-mind-research-say/103619394
Elon Musk says ketamine can get you out of a 'negative frame of mind' ...
Profile picture of The Washington Post
Medicare plans can cover Wegovy for patients with heart conditions: The federal government said that its prescription drug insurance for seniors will cover the ...
washingtonpost.com/business/2024/03/21/wegovy-medicare-part-d/
Medicare plans can cover Wegovy for patients with heart conditions
Profile picture of CNN.com
FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’
cnn.com/2024/03/26/health/winrevair-pah-drug-approval/
FDA approves new drug that may help stop and even reverse a rare ...
Profile picture of CNN.com
FDA renews proposed ban on electrical stimulation devices: The US Food and Drug Administration is again proposing a ban on electrical stimulation devices used to ...
cnn.com/2024/03/25/health/fda-ban-electrical-stimulation-devices/
FDA renews proposed ban on electrical stimulation devices
Profile picture of CNN.com
Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors
cnn.com/2024/03/26/health/medicare-ozempic-diabetes-drugs-spending/
Medicare spending on Ozempic and similar diabetes drugs soars, study finds ...
Profile picture of Reuters
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
Regeneron's blood cancer therapy faces setback as FDA raises trial ...
Profile picture of USA Today
6.9 million Americans have Alzheimer's disease: How to reduce your risk: Public and private spending to take care of Alzheimer's and dementia patients will ...
usatoday.com/story/news/health/2024/03/20/alzheimers-association-disease-report/72963017007/
6.9 million Americans have Alzheimer's disease: How to reduce your risk
Profile picture of Politico
Manchin says Biden’s reelection is in jeopardy: At POLITICO’s Health Care Summit, the West Virginia Democrat took aim at the president on fentanyl overdoses and ...
politico.com/news/2024/03/13/manchin-biden-reelection-jeopardy-00146763
Manchin says Biden’s reelection is in jeopardy
Profile picture of CNN.com
FDA approved a lifesaving therapy for children with a rare genetic disease. It might become the world’s most expensive drug
cnn.com/2024/03/19/health/gene-therapy-orchard-mld/
FDA approved a lifesaving therapy for children with a rare genetic disease ...
Profile picture of The Washington Post
DNA test says it can predict opioid addiction risk. Skeptics aren’t so sure.: The Food and Drug Administration approved the test despite an agency committee of ...
washingtonpost.com/health/2024/03/25/dna-test-opioid-addiction/
DNA test says it can predict opioid addiction risk. Skeptics aren’t so ...
Profile picture of Healthline
FDA Delays Approval for Eli Lilly’s Experimental Alzheimer’s Treatment: FDA approval of Eli Lilly’s experimental Alzheimer’s drug donanemab will be delayed ...
healthline.com/health-news/fda-delays-approval-eli-lilly-alzheimers-drug
FDA Delays Approval for Eli Lilly’s Experimental Alzheimer’s Treatment
Profile picture of Newsweek
Medicare Gets Big Change: Wegovy, a weight-loss drug, has been approved for coverage for patients on Medicare who have a history of heart disease.
newsweek.com/wegovy-approved-medicare-insurance-heart-disease-1883177
Medicare Gets Big Change
Profile picture of The Hindu
The way we name cancers could affect access to treatment, researchers say: Revamping cancer classification to focus on molecular characteristics over organ of ...
thehindu.com/sci-tech/science/precision-oncology-cancer-naming-scheme-revamp/article67968096.ece
The way we name cancers could affect access to treatment, researchers say
Profile picture of Time
The Most Exciting New Advances in Managing COPD: From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines ...
time.com/6903546/copd-treatment-advances/
The Most Exciting New Advances in Managing COPD
Profile picture of Scientific American
Wegovy Is First Weight-Loss Drug Approved for Heart Diseases: The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some ...
scientificamerican.com/article/wegovy-is-first-weight-loss-drug-approved-for-heart-diseases/
Wegovy Is First Weight-Loss Drug Approved for Heart Diseases
Profile picture of ABC News
White House launches new effort to prevent opioid overdoses: A senior official said what they've done so far is "not nearly enough."
abcnews.go.com/Politics/white-house-launches-new-effort-prevent-opioid-overdose/story
White House launches new effort to prevent opioid overdoses
Profile picture of Reuters
US FDA staff flags concerns about Geron's anemia treatment: The U.S. health regulator's staff on Tuesday flagged concerns that the late-stage trial data on ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flags-concerns-about-gerons-anemia-treatment-2024-03-12/
US FDA staff flags concerns about Geron's anemia treatment
Profile picture of IEEE Spectrum
Pressure-Relief Eye Tech Advances Toward Approval: FDA panel’s green light on glaucoma wearable device offers hope in sight
spectrum.ieee.org/glaucoma-treatment-device
Pressure-Relief Eye Tech Advances Toward Approval
Profile picture of NBC News
Narcan accessibility varies store-to-store across U.S., making life-saving opioid overdose drug harder to find
nbcnews.com/health/health-news/narcan-opioid-overdose-drug-otc-access-varies-us-stores-rcna135324
Narcan accessibility varies store-to-store across U.S., making life-saving ...
Profile picture of CNBC
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
cnbc.com/2024/03/19/healthy-returns-first-nash-liver-disease-drug-is-here-more-coming.html
Healthy Returns: The first drug for a common, deadly liver disease is here ...
Profile picture of Axios (website)
Setbacks reset views on highly touted Alzheimer's and ALS drugs: Treatments widely touted by patients aren't necessarily a sure thing.
axios.com/2024/03/11/setbacks-drugs-als-alzheimers-fda
Setbacks reset views on highly touted Alzheimer's and ALS drugs
Profile picture of Axios (website)
Growing market for glucose monitoring fueled by nondiabetics: Weight-loss drugs are helping fuel broader interest in the devices, even as many doctors have mixed ...
axios.com/2024/03/19/glucose-monitoring-blood-sugar-diabetes
Growing market for glucose monitoring fueled by nondiabetics
Profile picture of Forbes
California Legislator Proposes Banning These Food Dyes In Public Schools Over Alleged ADHD Link—Here’s Why
forbes.com/sites/maryroeloffs/2024/03/12/california-legislator-proposes-banning-these-food-dyes-in-public-schools-over-alleged-adhd-link-heres-why/
California Legislator Proposes Banning These Food Dyes In Public Schools ...
Profile picture of The Atlantic
The Ozempic Revolution Is Stuck: Millions more Americans are now eligible for obesity drugs. But the injections remain maddeningly hard to find.
theatlantic.com/health/archive/2024/03/ozempic-revolution-stuck/677736/
The Ozempic Revolution Is Stuck
Profile picture of Newsweek
Cinnamon Recall Widens Over Metal Poisoning Fears: Four companies have issued recalls of the spice product this week after samples were found to contain elevated ...
newsweek.com/cinnamon-recall-widens-metal-poisoning-fears-lead-1877649
Cinnamon Recall Widens Over Metal Poisoning Fears
Profile picture of Bloomberg
Zepbound Shortage: Eli Lilly Weight-Loss Drug Faces Backorders: Eli Lilly’s new weight-loss shot is on backorder across the US, even as the FDA says there’s ...
bloomberg.com/news/articles/2024-03-26/zepbound-shortage-eli-lilly-weight-loss-drug-faces-backorders
Zepbound Shortage: Eli Lilly Weight-Loss Drug Faces Backorders
Profile picture of Bloomberg
Merck’s (MRK) Winrevair for Rare High Blood Pressure Disorder Approved by FDA: Merck & Co. won US approval for a new treatment for a rare, dangerous form of ...
bloomberg.com/news/articles/2024-03-26/merck-drug-for-rare-high-blood-pressure-disorder-approved-in-us
Merck’s (MRK) Winrevair for Rare High Blood Pressure Disorder Approved by ...
Profile picture of Daily Breeze
Libraries expand Naloxone clinics, training at Los Angeles County libraries: Naloxone, also known as Narcan, is an FDA-approved nasal spray that can quickly ...
pasadenastarnews.com/2024/03/27/libraries-expand-naloxone-clinics-training-at-los-angeles-county-libraries/
Libraries expand Naloxone clinics, training at Los Angeles County ...
Profile picture of Investor's Business Daily
Diabetes Play Tops Buy Point In Rally To New Highs: Dexcom stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the ...
investors.com/stock-lists/sector-leaders/dexcom-dxcm-stock/
Diabetes Play Tops Buy Point In Rally To New Highs
Profile picture of WTVF
There's a new drug in the fight against COVID. Pemgarda is an infusion drug made for those who are immunocompromised. This week ... Show more
Profile picture of The Boston Globe
Stoke Therapeutic reports encouraging results for epilepsy drug: The gene-based drug reduced the frequency of seizures by 43 percent to 85 percent in 34 patients ...
bostonglobe.com/2024/03/26/business/stoke-epilepsy-edward-kaye-dravet-syndrome-food-and-drug-administration/
Stoke Therapeutic reports encouraging results for epilepsy drug
Profile picture of The Boston Globe
FDA seeks new ban on shock devices used by Massachusetts school for students with disabilities
bostonglobe.com/2024/03/26/metro/fda-seeks-new-ban-on-shock-devices-used-by-mass-school/
FDA seeks new ban on shock devices used by Massachusetts school for ...
Profile picture of The Oklahoman
When it comes to the flu vaccine, are two doses better than one? | Bodyworks: Have studies shown that a second dose of the flu vaccine provide better protection?
oklahoman.com/story/lifestyle/2024/03/26/would-second-flu-shot-mean-better-protection-bodyworks/72971182007/
When it comes to the flu vaccine, are two doses better than one? | ...
Profile picture of The Boston Globe
Orchard Therapeutics gene therapy will carry $4.25 million list price: The gene therapy, which won the approval of the Food and Drug Administration on Monday ...
bostonglobe.com/2024/03/20/business/orchard-gene-therapy-metachromatic-leukodystrophy-mld-fda-bobby-gaspar/
Orchard Therapeutics gene therapy will carry $4.25 million list price
Profile picture of Financialexpress
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy: The FDA granted this application priority review and fast track designation ...
financialexpress.com/healthcare/pharma-healthcare/fda-gives-nod-to-nonsteroidal-treatment-for-duchenne-muscular-dystrophy/3435687/
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy
Profile picture of Taipei Times
Japanese red yeast rice supplements recalled over kidney risk: Bringing Taiwan to the World and the World to Taiwan
taipeitimes.com/News/taiwan/archives/2024/03/25/2003815456
Japanese red yeast rice supplements recalled over kidney risk
Profile picture of Financialexpress
The FDA granted this application priority review and fast track designation. It also received orphan drug and rare pediatric disease designations.
Profile picture of The Seattle Times
Death in rural WA jail points to failures in drug treatment: In the Klickitat County Jail, a young man killed himself during drug withdrawal ...
seattletimes.com/seattle-news/politics/fentanyl-crisis-descends-on-jail-in-a-small-wa-town-short-on-treatment/
Death in rural WA jail points to failures in drug treatment
Profile picture of Investor's Business Daily
Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal: AstraZeneca said Tuesday is would acquire Fusion Pharmaceuticals for $2 billion upfront ...
investors.com/news/technology/fusion-pharmaceuticals-astrazeneca-acquisition-biotech-stock/
Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal
Profile picture of Bloomberg
Oprah’s Ozempic Special Was a Missed Opportunity for Obesity: The Queen of All Media is trying to reset our national conversation about body size ...
bloomberg.com/opinion/articles/2024-03-19/oprah-s-ozempic-special-was-a-missed-opportunity-for-obesity
Oprah’s Ozempic Special Was a Missed Opportunity for Obesity
Profile picture of Bloomberg
Wegovy (NOVOB DC) for Heart Disease Now Covered by Medicare Part D Plans: Medicare prescription drug programs can now cover Novo Nordisk A/S’s blockbuster ...
bloomberg.com/news/articles/2024-03-21/medicare-drug-plans-can-now-cover-wegovy-for-heart-disease
Wegovy (NOVOB DC) for Heart Disease Now Covered by Medicare Part D Plans
Profile picture of The Oklahoman
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause harmful side effects
usatoday.com/story/news/health/2024/03/21/lawsuits-ozempic-wegovy-weight-loss-drugs-diabetes-harmful/72947158007/
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause ...
Profile picture of Fast Company
Novo Nordisk’s weight-loss wonder drugs could also help with dementia, liver disease, and more
fastcompany.com/91042014/novo-nordisk-most-innovative-companies-2024
Novo Nordisk’s weight-loss wonder drugs could also help with dementia ...